A company insider recently sold 11,040 shares of OptiNose Inc. [OPTN]. Should You Sale?


Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. OptiNose Inc. shares valued at $19,762 were sold by Mahmoud Ramy A on Mar 16. At $1.79 per share, Mahmoud Ramy A sold 11,040 shares. The insider’s holdings dropped to 517,128 shares worth approximately $0.66 million following the completion of this transaction.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.


Also, Marino Michael F III sold 4,972 shares, netting a total of over 8,900 in proceeds. Following the sale of shares at $1.79 each, the insider now holds 333,573 shares.

Before that, Miller Peter K had sold 29,664 shares from its account. In a trade valued at $52,505, the Chief Executive Officer traded OptiNose Inc. shares for $1.77 each. Upon closing the transaction, the insider’s holdings decreased to 29,664 shares, worth approximately $1.08 million.

Analyzing OPTN Stock Performance

On Thursday, OptiNose Inc. [NASDAQ: OPTN] plunged -5.93% to $1.27. The stock’s lowest price that day was $1.24, but it reached a high of $1.36 in the same session. During the last five days, there has been a drop of approximately -29.05%. Over the course of the year, OptiNose Inc. shares have dropped approximately -31.35%. Shares of the company reached a 52-week high of $2.0700 on 04/18/23 and a 52-week low of $1.2400 on 05/25/23. A 50-day SMA is recorded $1.8163, while a 200-day SMA reached $2.3711. Nevertheless, trading volume fell to 0.66 million shares from 0.63 million shares the previous day.

Support And Resistance Levels for OptiNose Inc. (OPTN)

According to the 24-hour chart, there is a support level at 1.2200, which, if violated, would cause prices to drop to 1.1700. In the upper region, resistance lies at 1.3400. The next price resistance is at 1.4100. RSI (Relative Strength Index) is 30.96 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.3373, which suggests the price will decrease in the coming days. Percent R is at 96.20%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.

Is OptiNose Inc. subject to short interest?

Stocks of OptiNose Inc. saw a sharp steep in short interest on May 14, 2023 dropping by -0.12 million shares to 2.41 million. Data from Yahoo Finance shows that the short interest on Apr 13, 2023 was 2.53 million shares. A decline of -4.98% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 14.95 of the overall float, the days-to-cover ratio (short ratio) decline to 14.95.

Which companies own the most shares of OptiNose Inc. (OPTN)?

According to Fidelity Management & Research Co filings, the company currently owns 14,854,006 shares, which is about 13.29% of the total OPTN shares outstanding. The investor’s shares have appreciated by 207,739 from its previous 13-F filing of 14646267.0 shares. A total of 0 shares of OptiNose Inc. were bought by Velan Capital Investment Manageme during the quarter, and -839 were sold by The Vanguard Group, Inc. In its current portfolio, Medical Strategy GmbH holds 2,895,825 shares valued at $4.95 million.

In terms of OptiNose Inc. share price expectations, FactSet research, analysts set an average price target of $4.00 in the next 12 months, up nearly 196.3% from the previous closing price of $1.35. Analysts anticipate OptiNose Inc. stock to reach $5.00 by 2023, with the lowest price target being $3.00. In spite of this, 3 analysts ranked OptiNose Inc. stock as a Buy at the end of 2023.


Please enter your comment!
Please enter your name here